SSA
Schonfeld Strategic Advisors Portfolio holdings
AUM
$13.3B
1-Year Return
26.83%
This Quarter Return
+11.83%
1 Year Return
+26.83%
3 Year Return
+97.05%
5 Year Return
+189.63%
10 Year Return
–
AUM
$589M
AUM Growth
+$142M
(+32%)
Cap. Flow
+$119M
Cap. Flow
% of AUM
20.29%
Top 10 Holdings %
Top 10 Hldgs %
17.62%
Holding
641
New
225
Increased
94
Reduced
75
Closed
242
Top Buys
| 1 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$14M |
| 2 |
Amazon
AMZN
|
+$13.9M |
| 3 |
Dell
DELL
|
+$11.6M |
| 4 |
Molson Coors Class B
TAP
|
+$10.8M |
| 5 |
Independence Realty Trust
IRT
|
+$9M |
Top Sells
| 1 |
Charter Communications
CHTR
|
+$12.7M |
| 2 |
Fortinet
FTNT
|
+$7.97M |
| 3 |
UNIT
Uniti Group
UNIT
|
+$7.72M |
| 4 |
Trane Technologies
TT
|
+$5.9M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$5.46M |
Sector Composition
| 1 | Technology | 19.8% |
| 2 | Consumer Discretionary | 17.39% |
| 3 | Healthcare | 11.58% |
| 4 | Communication Services | 9.88% |
| 5 | Financials | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Rio Tinto
RIO
$104B
| $365K | 0.06% |
10,940
-12,461
| -53% | -$416K |
|
|
OTIC
302
DELISTED
Otonomy, Inc.
OTIC
| $364K | 0.06% |
+20,000
| New | +$364K |
|
303
ENI
E
$52.1B
| $350K | 0.06% |
+12,134
| New | +$350K |
|
304
Berkshire Hathaway Class B
BRK.B
$1.07T
| $344K | 0.06% |
+2,378
| New | +$344K |
|
305
Avis
CAR
$5.5B
| $339K | 0.06% |
+9,904
| New | +$339K |
|
306
Applied Materials
AMAT
$129B
| $333K | 0.06% |
11,058
-85,428
| -89% | -$2.57M |
|
307
Ambarella
AMBA
$3.59B
| $331K | 0.06% |
+4,500
| New | +$331K |
|
|
CPE
308
DELISTED
Callon Petroleum Company
CPE
| $331K | 0.06% |
2,105
+498
| +31% | +$78.3K |
|
309
Charles Schwab
SCHW
$170B
| $326K | 0.06% |
10,334
-46,234
| -82% | -$1.46M |
|
310
General Dynamics
GD
$86.8B
| $318K | 0.05% |
+2,047
| New | +$318K |
|
311
Corpay
CPAY
$22B
| $317K | 0.05% |
1,823
-5,580
| -75% | -$970K |
|
312
BJ's Restaurants
BJRI
$742M
| $306K | 0.05% |
+8,623
| New | +$306K |
|
313
lululemon athletica
LULU
$19.9B
| $306K | 0.05% |
5,025
+763
| +18% | +$46.5K |
|
|
ALDR
314
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $305K | 0.05% |
9,321
+106
| +1% | +$3.47K |
|
315
Enanta Pharmaceuticals
ENTA
$190M
| $303K | 0.05% |
11,376
-3,639
| -24% | -$96.9K |
|
316
ON Semiconductor
ON
$20B
| $299K | 0.05% |
24,219
+13,895
| +135% | +$172K |
|
317
TruBridge
TBRG
$300M
| $296K | 0.05% |
+11,338
| New | +$296K |
|
|
TRIL
318
DELISTED
Trillium Therapeutics Inc.
TRIL
| $296K | 0.05% |
20,000
| – | – |
|
319
Qualcomm
QCOM
$173B
| $295K | 0.05% |
+4,312
| New | +$295K |
|
320
GSK
GSK
$80.6B
| $294K | 0.05% |
5,454
+474
| +10% | +$25.6K |
|
321
Minerva Neurosciences
NERV
$15.2M
| $289K | 0.05% |
+2,560
| New | +$289K |
|
322
MGM Resorts International
MGM
$9.85B
| $285K | 0.05% |
10,958
-73,976
| -87% | -$1.92M |
|
323
Esperion Therapeutics
ESPR
$506M
| $278K | 0.05% |
+20,062
| New | +$278K |
|
324
Fortive
FTV
$16.2B
| $277K | 0.05% |
+6,508
| New | +$277K |
|
325
Neurocrine Biosciences
NBIX
$14.3B
| $274K | 0.05% |
5,419
-81,244
| -94% | -$4.11M |
|